EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

Shares of Biogen Inc. BIIB slid 1.10% to $142.34 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Boston Properties (NYSE:BXP) reported its fourth-quarter 2024 earnings, revealing a significant miss on earnings per share ...

Because US tariffs are applied to goods from all its trading partners, global exports and GDP decline. Lower global demand in ...

Chris Viehbacher spoke out about the uncertain policy environment for life sciences companies, though he didn't single ...

Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Spinraza pulled in $1.74bn in sales for Biogen in 2023, as per the ...

In its place, though, Griffin was buying Biogen (NASDAQ:BIIB ... taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and ...

Biogen Inc. (BIIB), headquartered in Cambridge, Massachusetts, specializes in discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Need a refresher? "You" is a psychological thriller series that delves deep into the mind ...